StabiLux Biosciences
$550.0K
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
StabiLux Biosciences is currently valued at N/A as of May 16, 2024. The company has raised a total of $1.9M in funding.
Investment Perspective
StabiLux Biosciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is StabiLux Biosciences Worth in 2025?
As of 2025, StabiLux Biosciences is valued at N/A, based on the company's Later Stage VC funding round in May 16, 2024. This valuation positions StabiLux Biosciences as one of the leading private companies in the sector.
StabiLux Biosciences Valuation History
StabiLux Biosciences's funding history demonstrates steady growth and investor confidence.
How StabiLux Biosciences Valuation is Determined
Private company valuations like StabiLux Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
StabiLux Biosciences Valuation FAQs
Is StabiLux Biosciences profitable?
StabiLux Biosciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does StabiLux Biosciences's valuation compare to competitors?
StabiLux Biosciences is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will StabiLux Biosciences IPO?
StabiLux Biosciences has not announced plans for an initial public offering. Until an IPO, investors can access StabiLux Biosciences shares through secondary market platforms.